Literature DB >> 30027470

Association of Genetic Variants in NF-kB with Susceptibility to Breast Cancer: a Case Control Study.

Rabeb M Ghali1,2, Sana Mahjoub1, Sonia Zaied3, Hanen Bhiri3, Wael Bahia1, Touhami Mahjoub1, Wassim Y Almawi4,5.   

Abstract

Insofar as altered NF-κB signaling stemming from the presence of specific genetic variants in NF-κB gene contribute to cancer pathogenesis, this study evaluated the association between NF-κB rs147574894/I552V, rs148626207/M860T rs3774937 and rs1598859 variants and breast cancer and associated features and complications. This was a retrospective case-control study, which involved 207 women with breast cancer, and 214 cancer-free women who served as controls. NF-κB genotyping was done by real-time PCR. Significantly higher rs3774937 minor allele frequencies (MAF), and lower rs147574894 MAF were seen among breast cancer patients, thereby imparting disease susceptibility and protective nature to these variants, respectively. Significant association of rs3774937 and rs147574894 genotypes with breast cancer was seen under the dominant model. Histological type and grade, molecular type, Her2 positivity and ER+/Her2- correlated positively, while distant metastasis negatively correlated with rs3774937. On the other hand, rs147574894 negatively correlated with histological type and grade, tumor size, Her2 positivity, molecular type, and ER+/Her2-, while rs148626207 correlated positively with histological grade, but negatively with distant metastasis and triple-negative status. Breast cancer-susceptible and -protective 4-locus haplotypes were also identified. This is the first report that addresses the contribution of NF-κB variants to the pathogenesis of breast cancer in Middle Eastern-North African population, and the first to document positive association of rs3774937 with breast cancer.

Entities:  

Keywords:  Allele; Breast cancer; Haplotype; Metastasis; NF-κB

Mesh:

Substances:

Year:  2018        PMID: 30027470     DOI: 10.1007/s12253-018-0452-2

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  27 in total

Review 1.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

2.  Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer.

Authors:  Joanne E Curran; Stephen R Weinstein; Lyn R Griffiths
Journal:  Cancer Lett       Date:  2002-12-15       Impact factor: 8.679

3.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

4.  Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based study.

Authors:  C A Purdie; L Baker; A Ashfield; S Chatterjee; L B Jordan; P Quinlan; D J A Adamson; J A Dewar; A M Thompson
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

Review 5.  Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology.

Authors:  Sören Beinke; Steven C Ley
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

6.  Cancer epidemiology and control in the arab world - past, present and future.

Authors:  Elsayed I Salim; Malcolm A Moore; Jawad A Al-Lawati; Jamal Al-Sayyad; Amin Bazawir; Abdulbari Bener; Marilys Corbex; Nagi El-Saghir; Omran S Habib; Wasim Maziak; Hamdi Cherif Mokhtar; Ibrahim Abdel-Barr Seif-Eldrin; Tomotaka Sobue
Journal:  Asian Pac J Cancer Prev       Date:  2009 Jan-Mar

Review 7.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

8.  Epidemiology of breast cancer in europe and Africa.

Authors:  Ganiy Opeyemi Abdulrahman; Ganiyu Adebisi Rahman
Journal:  J Cancer Epidemiol       Date:  2012-05-27

9.  Simultaneous Analysis of Wnt and NF-κB Signaling Pathways in Doxorubicin Sensitive and Methotrexate Resistant PLC/ PRF/5 Cells.

Authors:  Nasrin Shojaie; Seyed Mahmood Ghaffari
Journal:  Cell J       Date:  2016-01-17       Impact factor: 2.479

10.  Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study.

Authors:  Alexa J Resler; Kathleen E Malone; Lisa G Johnson; Mari Malkki; Effie W Petersdorf; Barbara McKnight; Margaret M Madeleine
Journal:  BMC Cancer       Date:  2013-05-01       Impact factor: 4.430

View more
  2 in total

1.  Impacts of LOC105371267 Variants on Breast Cancer Susceptibility in Northern Chinese Han Females: A Population-Based Case-Control Study.

Authors:  Linna Peng; Congmei Huang; Shishi Xing; Dandan Li; Chunjuan He; Yongjun He; Wei Yang; Tianbo Jin; Li Wang
Journal:  J Oncol       Date:  2021-08-28       Impact factor: 4.375

2.  Utility of Circulating Cell-Free DNA in Assessing Microsatellite Instability and Loss of Heterozygosity in Breast Cancer Using Human Identification Approach.

Authors:  Norah A Al Sharhan; Safia A Messaoudi; Saranya R Babu; AbdulRauf B Chaudhary; Abdullah A Alsharm; Abdulmajeed F Alrefaei; Sultan Kadasah; Muhammad Abu-Elmagd; Mourad Assidi; Abdelbaset Buhmeida; Ángel Carracedo; Wassim Y Almawi
Journal:  Genes (Basel)       Date:  2022-03-25       Impact factor: 4.141

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.